Cite this article
105
Downloads
2
Citations
73
Views
Announcements
Reviews in Cardiovascular Medicine (RCM) is published by IMR Press from Volume 19 Issue 1 (2018). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with MedReviews, LLC.
Open Access
Review
Antiplatelet Therapy, Cardiac Surgery, and the Risk of Bleeding: The Surgeon's Perspective
Show Less
1
Valley Heart and Vascular Institute, Ridgewood, NJ
Rev. Cardiovasc. Med. 2011, 12(S1), 40–46;
https://doi.org/10.3909/ricm12S1S0005
Published: 20 January 2011
Abstract
Antiplatelet therapy is widely accepted in the contemporary management of patients with coronary syndromes. Effective platelet inhibition can cause an increased risk of bleeding, which is more evident when patients are referred to surgical coronary revascularization. The cardiac surgeon should be familiar with all new antiplatelet drugs. In this article we compile the latest information about antiplatelet therapy and its impact on cardiac surgery.
Keywords
Antiplatelet therapy
Cardiac surgery
Bleeding complications